CN

Chintan Narsinhbhai Patel

Active Director Managing Director DIN 10774296
DIN 10774296 First appointment Sep 2024
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2024
Shareholding value •••• Premium profile

About Chintan Narsinhbhai Patel

Data last updated:

Chintan Narsinhbhai Patel is a Managing Director at Small I Pharmaceutical Private Limited (since 2024). Small I Pharmaceutical Private Limited reported revenue of ₹1.2 Lakh (FY 2025).

DIN 10774296
Primary Designation Managing Director
First Appointment 10 Sep 2024
Oldest Company Age 2 yrs
Largest company Small I Pharmaceutical Private Limited · ₹1.2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director10 Sep 20242024₹1.2 Lakh (FY 2025)Active

Board colleagues of Chintan Narsinhbhai Patel

Directorship timeline

Open interactive timeline →
Small I Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Chintan Narsinhbhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chintan Narsinhbhai Patel

Chintan Narsinhbhai Patel currently holds 1 directorship: Small I Pharmaceutical Private Limited (Managing Director, since 10 Sep 2024, revenue ₹1.2 Lakh (FY 2025)).

Chintan Narsinhbhai Patel was first appointed on 10 Sep 2024 as Managing Director at Small I Pharmaceutical Private Limited.

The current boards of Chintan Narsinhbhai Patel's companies include Snehaben Chintankumar Patel (Small I Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available